financetom
Business
financetom
/
Business
/
Vale studying alternatives for nickel assets amid challenging scenario
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Vale studying alternatives for nickel assets amid challenging scenario
May 25, 2025 9:09 PM

SAO PAULO, April 29 (Reuters) - Brazilian miner Vale

is studying alternatives for its nickel portfolio

including selling, making partnerships or idling assets, as the

market faces a challenging short-term scenario, Chief Executive

Gustavo Pimenta said on Tuesday.

Pimenta told reporters in Rio de Janeiro the market is

oversupplied due to output from Indonesia. "Nickel remains

attractive in the medium and long-term. The question is how to

remain profitable in the short term," he said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Top Premarket Decliners
Top Premarket Decliners
Jun 24, 2025
07:58 AM EDT, 06/24/2025 (MT Newswires) -- Upexi ( UPXI ) shares were 62% lower pre-bell Tuesday following an 8.1% increase on Monday. Maase ( MAAS ) stock was down 44%, paring Monday's rally. Indonesia Energy ( INDO ) shares were 29% lower following a 3.8% loss in the previous session. Robin Energy ( RBNE ) stock was down 25%,...
Bio-Techne, US Pharmacopeia Partner to Distribute Reference Standards
Bio-Techne, US Pharmacopeia Partner to Distribute Reference Standards
Jun 24, 2025
07:59 AM EDT, 06/24/2025 (MT Newswires) -- Bio-Techne ( TECH ) said Tuesday that it has entered a distribution agreement with US Pharmacopeia, which will allow the life sciences company to sell US Pharmacopeia's monoclonal antibody and recombinant adeno-associated virus reference standards alongside its analytical platforms. Financial terms of the deal were not disclosed. ...
Nuvation Bio Says Taletrectinib Added as Preferred Agent in National Comprehensive Cancer Network for Lung Cancer
Nuvation Bio Says Taletrectinib Added as Preferred Agent in National Comprehensive Cancer Network for Lung Cancer
Jun 24, 2025
07:53 AM EDT, 06/24/2025 (MT Newswires) -- Nuvation Bio ( NUVB ) said Tuesday that taletrectinib has been added as a preferred agent in the updated National Comprehensive Cancer Network clinical practice guidelines for non-small cell lung cancer, or NSCLC. The guidance now supports taletrectinib as a treatment option for both first-line and subsequent therapy in ROS1-positive NSCLC, including for...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved